A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo
about
Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infectionDendritic cell-based immunity and vaccination against hepatitis C virus infectionPostulates for validating TLR4 agonistsGlucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140.Rationally Designed TLR4 Ligands for Vaccine Adjuvant DiscoveryClassical Flt3L-dependent dendritic cells control immunity to protein vaccineDendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunityThe importance of adjuvant formulation in the development of a tuberculosis vaccine.Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.Current and novel approaches to vaccine development against tuberculosis.Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells.RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, EndocineMyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvantThe immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and toleranceTargeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesOld and new adjuvants.An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.Antigen presentation by B cells guides programing of memory CD4+ T-cell responses to a TLR4-agonist containing vaccine in mice.The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age.Successes and failures in human tuberculosis vaccine development.Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis.
P2860
Q26784265-D6F63378-DFC9-44AB-8F82-AA9DD7C7F26CQ26828003-F1CC8A1D-9B7C-4DA0-B63A-E243C5EA9095Q27023992-437A8F10-34E5-4652-9A49-8BDED3BF9C8FQ31076192-030EF1C7-864A-4B19-9848-D16A7F78D1FDQ33654530-14254B4E-76FA-4165-A3C1-74934C91C18FQ34089167-7C144726-95A4-44AC-A37B-A351ECD09E2CQ35680858-2C058020-E122-4F66-83D9-B0F7ED2F6279Q35783475-52BA5C38-E58C-49B8-BFD8-931C373EB716Q36237416-2C47AB40-D70C-4F0E-AD34-F88C133CB5CCQ36449189-0CCAAD75-3EC3-42CA-8C72-62049ACCBE0DQ36654119-2395F29E-49C9-4F91-8084-E5D28DB9B30DQ36957252-CD488694-3332-455C-9467-43F38BBCC11BQ36998340-CE992956-010A-4F2A-BC82-6E2C4F8863EFQ37061815-0224E046-775A-4FD2-BF53-C38931D749F2Q37243896-64AA6793-E751-4B60-91E0-0104C61D72E9Q37572673-80DDBC06-B745-4BBB-AEC1-6C2402DCB480Q38719738-9B0D2981-4194-4659-9836-7D1DDF231371Q39448911-E3D29444-9C24-4F5E-8E63-5EF1F0BED63AQ39451745-E204CB12-FCA1-412D-A64C-B607A6FD312DQ40095257-04C7768D-9F5B-43E3-8994-AA4DC7AD4D90Q40476014-8BED7612-C886-49F8-A9A6-2334B62F9CD0Q40517477-3E37F794-9B9E-424C-A73C-178B8EBBBF56Q41246444-58FB0B27-A4A0-4AED-A89A-8873DBE6D4E9Q41996442-8479FAE2-A589-4527-9187-C9E47B204950Q51743228-8373B59F-ADC8-4911-85EB-7F319EE946B5
P2860
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
A new synthetic TLR4 agonist, ...... it Th1 T-cell immunity in vivo
@ast
A new synthetic TLR4 agonist, ...... it Th1 T-cell immunity in vivo
@en
type
label
A new synthetic TLR4 agonist, ...... it Th1 T-cell immunity in vivo
@ast
A new synthetic TLR4 agonist, ...... it Th1 T-cell immunity in vivo
@en
prefLabel
A new synthetic TLR4 agonist, ...... it Th1 T-cell immunity in vivo
@ast
A new synthetic TLR4 agonist, ...... it Th1 T-cell immunity in vivo
@en
P2093
P2860
P356
P1476
A new synthetic TLR4 agonist, ...... it Th1 T-cell immunity in vivo
@en
P2093
Angela Teixeira
Austin Pantel
Cheolho Cheong
Darren Ruane
Durga Dandamudi
Elina Shrestha
Leonia Bozzacco
Luke Brane
M Paula Longhi
Ralph M Steinman
P2860
P304
P356
10.1002/EJI.201141855
P407
P577
2011-12-12T00:00:00Z